Home › Urothelial (Transitional Cell) Carcinoma › Florida › Orlando
Urothelial (Transitional Cell) Carcinoma clinical trials in Orlando, FL
7 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- AdventHealth Orlando, Orlando
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #48, Celebration · 17 mi away
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Clermont Oncology Center, Clermont · 24 mi away
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
RecruitingPhase 1
- Orlando Health, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Orlando
Urothelial (Transitional Cell) Carcinoma trials in other cities
- New York City, NY23 studies
- Nashville, TN22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Orange, CA10 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Metastatic Cancer29 studies
- Obesity29 studies
- Cancer (all types)25 studies
- Alzheimer's Disease25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ulcerative Colitis23 studies
- Ovarian Cancer22 studies
- Lung Cancer21 studies
- Colorectal Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.